Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal oxytocin for social behavior in autistic and antisocial male adults
2010-018740-13Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of oxytocin in Autism Spectrum Disorder (ASD) and antisocial personality disorder (ASPD) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Social functioning assessed by Social Responsiveness Scale and Symptom checklist score. Started Apr 2010; status: active.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)antisocial personality disorder (ASPD)
Beyond the preview
Go deeper on 2010-018740-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018740-13.